story of the week
PCSK9 Monoclonal Antibodies Do Not Significantly Affect New-Onset Diabetes or Glucose Metabolism
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Monoclonal Antibodies on New-Onset Diabetes Mellitus and Glucose Metabolism: A Systematic Review and Meta-Analysis
Diabetes Obes Metab 2018 Mar 07;[EPub Ahead of Print], YX Cao, HH Liu, QT Dong, S Li, JJ LiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.